Also trades as: LMDXW (NASDAQ) · $vol 0M
LMDX NASDAQ
LumiraDx Limited
1W: +15.1%
1M: +60.0%
3M: -83.2%
1Y: -98.7%
$0.02
Last traded 2025-06-17 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
#42
of 92
Medical - Diagnostics & Research
Technical Signal Map
0 Bullish
2 Neutral
6 Bearish
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| LMDX LumiraDx Limited | $10M | -0.0 | 342.9 | -147.4 | -236.8 | -68.2 | 1 | N/A | -98.7 |
| ABDX.L Abingdon Health Plc | $40M | -13.1 | -143.7 | -152.8 | -55.4 | 116.1 | 5 | NEUTRAL | 92.2 |
| VRCI.L Verici Dx plc | $10M | -0.6 | -240.8 | -287.3 | -219.5 | 548.9 | 4 | BEARISH | -57.1 |
| ANPCF Cellbxhealth PLC | $20M | — | -239.7 | -609.1 | -452.4 | -32.8 | 2 | BEARISH | -58.3 |
| GDR.L Genedrive Plc | $20M | -1.1 | -707.4 | -3299.5 | -480.5 | 1299.0 | 6 | BEARISH | 54.8 |
| HVO.L hVIVO plc | $80M | -3.3 | -20.0 | -21.2 | -39.7 | -28.1 | 2 | BEARISH | -40.0 |
| CLBX.L CelLBxHealth plc | $10M | — | — | — | — | — | — | BEARISH | — |
| GENI.L GENinCode plc | — | -0.5 | -419.6 | -8421.9 | -223.9 | 27.8 | 4 | BEARISH | -46.4 |
| LMDX LumiraDx Limited | $10M | -0.0 | 342.9 | -147.4 | -236.8 | -68.2 | 1 | N/A | -98.7 |
| ABDX.L Abingdon Health Plc | $40M | -13.1 | -143.7 | -152.8 | -55.4 | 116.1 | 5 | NEUTRAL | 92.2 |
| VRCI.L Verici Dx plc | $10M | -0.6 | -240.8 | -287.3 | -219.5 | 548.9 | 4 | BEARISH | -57.1 |
| ANPCF Cellbxhealth PLC | $20M | — | -239.7 | -609.1 | -452.4 | -32.8 | 2 | BEARISH | -58.3 |
| GDR.L Genedrive Plc | $20M | -1.1 | -707.4 | -3299.5 | -480.5 | 1299.0 | 6 | BEARISH | 54.8 |
| HVO.L hVIVO plc | $80M | -3.3 | -20.0 | -21.2 | -39.7 | -28.1 | 2 | BEARISH | -40.0 |
| CLBX.L CelLBxHealth plc | $10M | — | — | — | — | — | — | BEARISH | — |
| GENI.L GENinCode plc | — | -0.5 | -419.6 | -8421.9 | -223.9 | 27.8 | 4 | BEARISH | -46.4 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
LMDX vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F